| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/27/2003 | WO2003016493A2 Transporters and ion channels |
| 02/27/2003 | WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | WO2003016471A2 Periostin-based diagnostic assays |
| 02/27/2003 | WO2003016470A2 Enhancing the efficacy of immunotherapies by supplementing with complement |
| 02/27/2003 | WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies |
| 02/27/2003 | WO2003016467A2 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass |
| 02/27/2003 | WO2003016466A2 ANTI-Aβ ANTIBODIES |
| 02/27/2003 | WO2003016355A1 Pre-t cell receptor (pre-tcr) and the characterisation and regulation of the expression and function thereof during the development of t cells in humans |
| 02/27/2003 | WO2003016354A2 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | WO2003016353A1 Anti-ciguatoxin monoclonal antibody |
| 02/27/2003 | WO2003016352A1 Monoclonal antibodies against fungi and methods for their use |
| 02/27/2003 | WO2003016344A2 Use of lung carcinoma antigen |
| 02/27/2003 | WO2003016341A2 Regulation of iron uptake |
| 02/27/2003 | WO2003016337A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope |
| 02/27/2003 | WO2003016333A2 Virus coat protein/receptor chimeras and methods of use |
| 02/27/2003 | WO2003016328A1 Methods for the treatment and prevention of cancer |
| 02/27/2003 | WO2003015902A2 High strength asymmetric cellulosic membrane |
| 02/27/2003 | WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 02/27/2003 | WO2003015818A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 02/27/2003 | WO2003015817A2 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | WO2003015716A2 Immunoglobulin e vaccines and methods of use thereof |
| 02/27/2003 | WO2003015705A2 In situ immunization |
| 02/27/2003 | WO2003015697A2 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | WO2003015694A2 Agents for enhancing the immune response |
| 02/27/2003 | WO2003015691A2 RAPID IMPROVEMENT OF COGNITION IN CONDITIONS RELATED TO A$g(b) |
| 02/27/2003 | WO2003015617A2 Assay method for alzheimer's disease |
| 02/27/2003 | WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 02/27/2003 | WO2002099100A3 Method of production of a protein in cells which inducibly express the cell cycle inhibitor protein, p21 |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | WO2002094853A3 Antibodies specific for poly(ethylene glycol) |
| 02/27/2003 | WO2002089746A3 Hematopoietic stem cell chimerism to treat autoimmune disease |
| 02/27/2003 | WO2002086083A3 Methods of enhancing cell responsiveness |
| 02/27/2003 | WO2002074245A3 Anti-gpe antibodies, their uses, and analytical methods for gpe |
| 02/27/2003 | WO2002072752A3 Forms of prostate specific antigens and methods for their detection |
| 02/27/2003 | WO2002066492A3 Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof |
| 02/27/2003 | WO2002057422A3 Ternary biomolecule/polymer/surface-based immobilization systems |
| 02/27/2003 | WO2002055725A3 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 02/27/2003 | WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001079555A3 Roles of jak/stat family members in tolerance induction |
| 02/27/2003 | WO2001069253A3 3d model of an fc epsilon receptor alpha chain-ige fc region complex |
| 02/27/2003 | US20030041345 Nucleotide sequences coding enzymatic polypeptide for use in the propagation of plants |
| 02/27/2003 | US20030041344 Receptor kinase, BIN1 |
| 02/27/2003 | US20030040606 Reducing immunogenicities of immunoglobulins by framework-patching |
| 02/27/2003 | US20030040605 Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
| 02/27/2003 | US20030040604 Siglec-12 polypeptides, polynucleotides, and methods of use thereof |
| 02/27/2003 | US20030040603 Purified mammalian CTLA-8 antigens and related reagents |
| 02/27/2003 | US20030040476 EAG gene |
| 02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
| 02/27/2003 | US20030040093 Platelet activating factor acetylhydrolase, and gene thereof |
| 02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
| 02/27/2003 | US20030040078 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040071 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030040048 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 02/27/2003 | US20030040046 Netrin receptors |
| 02/27/2003 | US20030040045 Mammalian sweet taste receptors |
| 02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/27/2003 | US20030040041 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis |
| 02/27/2003 | US20030040039 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 02/27/2003 | US20030040029 Detection of tumor marker transcript and protein recognized by naive natural killer cells |
| 02/27/2003 | US20030040024 Method and kit for the diagnosis of troponin I |
| 02/27/2003 | US20030040023 Isolation of neural stem cells using gangliosides and other surface markers |
| 02/27/2003 | US20030040022 Dopamine receptors and genes |
| 02/27/2003 | US20030040014 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039997 Pentopyranosyl nucleic acid arrays, and uses thereof |
| 02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
| 02/27/2003 | US20030039972 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039971 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/27/2003 | US20030039969 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
| 02/27/2003 | US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases |
| 02/27/2003 | US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039659 Self antigen vaccines for treating B cell lymphomas and other cancers |
| 02/27/2003 | US20030039657 DNA sequences encoding polypeptides of pathogens and antigens and an additional DNA sequence encoding a regulatory moiety which can bind with an administered activating agent to induce expression of an immune response |
| 02/27/2003 | US20030039655 Novel engineered superantigen for human therapy |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039653 Identifying a mammal with, or at risk of developing, cancer; cells of the cancer are identified as expressing B7-H1 molecules on their surfaces, and administering an agent that interferes with interaction between B7-H1 and t-cells |
| 02/27/2003 | US20030039652 Inhibiting endothelial monocyte activating polypeptide II |
| 02/27/2003 | US20030039651 Administering tumor necrosis factor inhibitors, interleukin -1, -6, or -8 inhibitors, FAS (ligand) gene/protein inhibitors or interferon gamma inhibitors; nerve disorder treatments |
| 02/27/2003 | US20030039649 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences |
| 02/27/2003 | US20030039647 Tetraspan protein and uses thereof |
| 02/27/2003 | US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells |
| 02/27/2003 | US20030039645 Humanised antibodies |
| 02/27/2003 | US20030039643 Investigation, diagnosis and treatment of subjects suspected of or suffering from alpha-N- acetylglucosaminidase deficiency |
| 02/27/2003 | US20030039641 Cells expressing anti-fc receptor binding components |
| 02/27/2003 | US20030039632 Novel bacteriocins, transport and vector system and method of use thereof |
| 02/27/2003 | US20030039611 Selectively binds to antigen to cause cell impairment |